ZYGMONT CHESTER STANLEY III (Chief Financial Officer) reported 1 transaction at REVELATION BIOSCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/5/2026ACC: 0001193125-26-039686
Officer· Chief Financial Officer
Since Jan 2022
-13.10K
Net shares
Net seller
$21.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
13.10K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−13.10K
Price / share
$1.65
Trade value
$21.61K
% of position
11.1%
2/4/2026
118.45K→105.35K
Total
Net shares
−13.10K
Net value
-$21.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/4/2026 | F · Tax Withholding | −13.10K | $1.65 | $21.61K | 11.1% | 118.45K | 105.35K |
| Total | −13.10K | -$21.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.00
Total
2.00 indirect2.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.00 | Indirect |
| Total | 2.00 | 2.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported